A Bayer AG unit will pay $15 million to settle a U.S. lawsuit claiming it illegally marketed aspirin mixed with supplements.
The settlement between the unit, Bayer Healthcare LLC, and U.S. consumers received preliminary approval today from a federal judge in Brooklyn, New York.
